GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Choong Ang Vaccine Laboratory Co Ltd (XKRX:072020) » Definitions » Debt-to-Equity

Choong Ang Vaccine Laboratory Co (XKRX:072020) Debt-to-Equity : 0.08 (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Choong Ang Vaccine Laboratory Co Debt-to-Equity?

Choong Ang Vaccine Laboratory Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩2,250 Mil. Choong Ang Vaccine Laboratory Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩5,761 Mil. Choong Ang Vaccine Laboratory Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩99,964 Mil. Choong Ang Vaccine Laboratory Co's debt to equity for the quarter that ended in Mar. 2024 was 0.08.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Choong Ang Vaccine Laboratory Co's Debt-to-Equity or its related term are showing as below:

XKRX:072020' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01   Med: 0.11   Max: 0.18
Current: 0.08

During the past 13 years, the highest Debt-to-Equity Ratio of Choong Ang Vaccine Laboratory Co was 0.18. The lowest was 0.01. And the median was 0.11.

XKRX:072020's Debt-to-Equity is ranked better than
75.27% of 845 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs XKRX:072020: 0.08

Choong Ang Vaccine Laboratory Co Debt-to-Equity Historical Data

The historical data trend for Choong Ang Vaccine Laboratory Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Choong Ang Vaccine Laboratory Co Debt-to-Equity Chart

Choong Ang Vaccine Laboratory Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.12 0.13 0.13 0.11

Choong Ang Vaccine Laboratory Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.12 0.14 0.11 0.08

Competitive Comparison of Choong Ang Vaccine Laboratory Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Choong Ang Vaccine Laboratory Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Choong Ang Vaccine Laboratory Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Choong Ang Vaccine Laboratory Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Choong Ang Vaccine Laboratory Co's Debt-to-Equity falls into.



Choong Ang Vaccine Laboratory Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Choong Ang Vaccine Laboratory Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Choong Ang Vaccine Laboratory Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Choong Ang Vaccine Laboratory Co  (XKRX:072020) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Choong Ang Vaccine Laboratory Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Choong Ang Vaccine Laboratory Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Choong Ang Vaccine Laboratory Co (XKRX:072020) Business Description

Traded in Other Exchanges
N/A
Address
1476-37 Yongsan-dong, Yuseong-gu, Daejeon, KOR, 305-348
Choong Ang Vaccine Laboratory Co., Ltd. manufactures and markets vaccines for animals. The company specialized in vaccines for animals and is the largest one in Korea. The company has a solid financial structure.

Choong Ang Vaccine Laboratory Co (XKRX:072020) Headlines

No Headlines